The next board meeting for Carisma Therapeutics Inc is on 08 Aug 2025 for the purpose of CARISMA Therapeutics Inc Second Quarter Earnings Results for 2025See details
Carisma Therapeutics Inc has a share price target of US$ 1, revenue growth forecast of -23.6%, and profit growth estimate of 72.0% for FY25, based on top 2 analyst calls.